Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 30, 2025 • 9:31 AM ET

Date/Time Source News Release
07/23/2025 08:03 AM EDT Business Wire Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series
07/15/2025 09:03 AM EDT Business Wire Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)
06/24/2025 09:03 AM EDT Business Wire Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003
06/16/2025 10:46 AM EDT Business Wire Enveric Biosciences Announces Participation in 2025 BIO International Convention
06/10/2025 09:03 AM EDT Business Wire Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders
06/03/2025 09:00 AM EDT Business Wire Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds
05/28/2025 09:03 AM EDT Business Wire Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003
05/20/2025 08:00 AM EDT Business Wire Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease
05/14/2025 04:15 PM EDT Business Wire Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results
03/31/2025 08:00 AM EDT Business Wire Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024
Page

Additional News

As of July 30, 2025 • 9:31 AM ET

Date/Time Source News Release
06/23/2025 03:24 PM EDT SeekingAlpha Psychedelic medicine stocks fall following Compass depression asset data
05/20/2025 10:46 AM EDT SeekingAlpha Psychedelic stocks rise as FDA chief's comments seen favorable to industry
05/14/2025 05:55 PM EDT SeekingAlpha Enveric Biosciences GAAP EPS of -$1.22
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Enveric Biosciences Inc.
03/31/2025 08:17 AM EDT SeekingAlpha Enveric Biosciences GAAP EPS of -$19.04
03/24/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, March 24th, 2025
03/24/2025 05:30 AM EDT US Earnings Reports Expected earnings - Enveric Biosciences Inc.
02/26/2025 02:50 PM EST InvestorIdeas.com Biotech Stock Enveric Biosciences Soars on Patent News
02/26/2025 02:35 PM EST AllPennyStocks.com This Biotech Soared On Key Announcement
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.